GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lifecore Biomedical Inc (NAS:LFCR) » Definitions » Shiller PE Ratio

Lifecore Biomedical (Lifecore Biomedical) Shiller PE Ratio : (As of Apr. 28, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Lifecore Biomedical Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lifecore Biomedical Shiller PE Ratio Historical Data

The historical data trend for Lifecore Biomedical's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecore Biomedical Shiller PE Ratio Chart

Lifecore Biomedical Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.42 41.15 87.41 - -

Lifecore Biomedical Quarterly Data
Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lifecore Biomedical's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecore Biomedical's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Shiller PE Ratio falls into.



Lifecore Biomedical Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lifecore Biomedical's E10 for the quarter that ended in May. 2023 is calculated as:

For example, Lifecore Biomedical's adjusted earnings per share data for the three months ended in May. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of May. 2023 (Change)*Current CPI (May. 2023)
=-1.19/128.3144*128.3144
=-1.190

Current CPI (May. 2023) = 128.3144.

Lifecore Biomedical Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201308 0.180 98.675 0.234
201311 0.130 98.334 0.170
201402 0.240 99.057 0.311
201405 0.169 100.373 0.216
201408 0.090 100.352 0.115
201411 0.120 99.635 0.155
201502 0.140 99.032 0.181
201505 0.150 100.333 0.192
201508 0.110 100.548 0.140
201511 0.070 100.135 0.090
201602 -0.780 100.040 -1.000
201605 0.170 101.355 0.215
201608 0.120 101.617 0.152
201611 0.050 101.829 0.063
201702 0.130 102.779 0.162
201705 0.089 103.256 0.111
201708 0.080 103.587 0.099
201711 0.020 104.072 0.025
201802 0.570 105.052 0.696
201805 0.220 106.148 0.266
201808 0.010 106.383 0.012
201811 -0.020 106.338 -0.024
201902 0.030 106.649 0.036
201905 -0.010 108.048 -0.012
201908 -0.160 108.245 -0.190
201911 -0.230 108.519 -0.272
202002 -0.390 109.139 -0.459
202005 -0.520 108.175 -0.617
202008 -0.380 109.662 -0.445
202011 -0.450 109.793 -0.526
202102 -0.190 110.968 -0.220
202105 -0.100 113.576 -0.113
202108 -0.320 115.421 -0.356
202111 -1.300 117.269 -1.422
202202 -0.450 119.703 -0.482
202205 -1.240 123.323 -1.290
202208 -0.380 124.958 -0.390
202211 -0.420 125.607 -0.429
202302 -1.330 126.928 -1.345
202305 -1.190 128.314 -1.190

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lifecore Biomedical  (NAS:LFCR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Lifecore Biomedical Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecore Biomedical (Lifecore Biomedical) Business Description

Traded in Other Exchanges
N/A
Address
3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid.
Executives
Raymond T. White director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Holdings, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. Ii director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. I director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Asset Management, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Christopher S Kiper director 12121 WILSHIRE BLVD, SUITE 1240, LOS ANGELES CA 90025
Nathaniel Calloway director C/O ANEBULO PHARMACEUTICALS, INC., 1415 RANCH ROAD 620 SOUTH, SUITE 201, LAKEWAY TX 78734
Wynnefield Partners Small Cap Value Lp I 10 percent owner 450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Raymond H Diradoorian director C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Joshua Schechter director C/O THE PANTRY, INC., 305 GREGSON DRIVE, CARY NC 27511
Patrick D Walsh director 14282 FRANKLIN AVE., TUSTIN CA 92780
John D Morberg officer: Chief Financial Officer C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Albert D. Bolles director CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
James G Hall officer: Executive Vice President 3515 LYMAN BLVD., CHASKA MN 55318

Lifecore Biomedical (Lifecore Biomedical) Headlines

From GuruFocus